View All News

Lygos Closes Series B Financing

We are excited to announce the close of Lygos’ $15.5MM Series B round of financing. Led by IA Ventures and First Round Capital, these funds will be used to accelerate commercialization of our pipelined products and expand our technology platform. Having successfully developed a bio-based route to malonates, we now look forward to bringing new aspartic, glycolic, and lactic acid technologies to market, among others.

Read more:

Lygos Raises $15.5 Million to Accelerate Delivery of Clean and Sustainable Biology-Based Performance Materials. Globe Newswire (July 2018)

More News
August 1, 2020
Forbes – Can This California Startup Brew Sustainable, Guilt-Free Plastic From Sugar?
June 16, 2020
Praj and Lygos to Co-develop Advanced Lactic Acid Yeast Technology for Bio-based Products
January 15, 2020
Lygos Acquires Librede to Accelerate Cannabinoid Production for Consumer, Nutraceutical and Pharmaceutical Products